News | Radiation Therapy | April 07, 2022

ASTRO released a statement in response to the proposed rule issued April 6 by CMS that will delay the Radiation Oncology (RO) Model, which was scheduled to go into effect in January 1, 2023

The American Society for Radiation Oncology (ASTRO) issued the following statement from ASTRO Board of Directors Chair Laura A. Dawson, MD, FASTRO, in response to the Centers for Medicare and Medicaid Services' (CMS) decision to delay the start of the Radiation Oncology Alternative Payment Model (RO-APM)

Getty Images


April 7, 2022 — The American Society for Radiation Oncology (ASTRO) issued the following statement from ASTRO Board of Directors Chair Laura A. Dawson, MD, FASTRO, in response to the Centers for Medicare and Medicaid Services' (CMS) decision to delay the start of the Radiation Oncology Alternative Payment Model (RO-APM):

"The Centers for Medicare and Medicaid Services today delayed the Radiation Oncology Alternative Payment Model start date from January 1, 2023, to a date to be determined through future rulemaking.  ASTRO remains hopeful that during this process, CMS also makes the adjustments recommended by Congress and the broad coalition of stakeholders within the radiation oncology community as we remain concerned that the model in its current form is too punitive for clinics. We remain committed to value-based care in radiation oncology. We believe that the modifications proposed by ASTRO and the radiation oncology community will ensure successful participation among physicians and facilities and produce significant savings for the Medicare program.  We continue to believe that episodic payments for radiation therapy services have great potential to improve quality and equity while reducing cancer care costs, and we will continue to advocate for proposals that achieve these goals.”

For more information: www.astro.org

Related CMS Content:

ASTRO Urges Congress to Pass Legislation Delaying RO Model and Protecting Medicare Beneficiaries' Access to Care

ASTRO Deeply Concerned and Disappointed Over CMS 2022 Final Rules

Senators and representatives unite to call on CMS to protect patient access to high-quality radiation treatments

 


Related Content

Feature | Radiology Imaging | By Melinda Taschetta-Millane

It's been a fruitful month for itnonline.com! Here's a look at what ITN viewers found to be most interesting during the ...

Time June 01, 2023
arrow
News | Radiation Oncology

May 31, 2023 — Elekta announced the launch of the first phase of Elekta ONE*, its most comprehensive and advanced ...

Time May 31, 2023
arrow
News | Radiation Therapy

May 30, 2023 — The first treatment, for a patient with prostate cancer, was successfully carried out on April 28. Yonsei ...

Time May 30, 2023
arrow
News | Oncology Information Management Systems (OIMS)

May 24, 2023 — RaySearch Laboratories AB announced that the oncology information system RayCare* (* subject to ...

Time May 24, 2023
arrow
News | ASTRO

May 23, 2023 — More than 9 in 10 radiation oncologists report that their practices face clinical staff shortages ...

Time May 23, 2023
arrow
News | Radiation Oncology

May 23, 2023 — ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that ...

Time May 23, 2023
arrow
News | Radiation Oncology

May 22, 2023 — Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center will discuss the latest ...

Time May 22, 2023
arrow
News | Radiation Oncology

May 18, 2023 — Cassling announced it is a new strategic sales agent in various geographic territories across the United ...

Time May 18, 2023
arrow
News | Radiation Oncology

May 16, 2023 — The American Society for Radiation Oncology (ASTRO) today expressed its strong support for President ...

Time May 16, 2023
arrow
News | Radiation Therapy

May 15, 2023 — GE HealthCare is presenting three new global innovations – Intelligent Radiation Therapy (iRT), Auto ...

Time May 15, 2023
arrow
Subscribe Now